drug-coated balloon
- Open AccessSafety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery DiseaseKenneth Ouriel, Daniel G. Clair, et al.JACC: Cardiovascular Interventions
- Access DeniedPaclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial InfarctionThe REVELATION Randomized TrialNicola S. Vos, Maarten A. Vink, et al.JACC: Cardiovascular Interventions
- Access DeniedLeaving Nothing Behind in Treatment of Acute Myocardial InfarctionAre We There Yet?Omeed Neghabat, Niels Ramsing Holm, et al.JACC: Cardiovascular Interventions
- Open AccessDrug-Coated Balloon Treatment for Femoropopliteal Artery DiseaseThe Chronic Total Occlusion Cohort in the IN.PACT Global StudyGunnar Tepe, Michael R. Jaff, et al.JACC: Cardiovascular Interventions
- Access DeniedIn Front of Locked Doors—Femoropopliteal Chronic OcclusionsIs Drug-Coated Balloon Angioplasty With Provisional Stenting the Matching Key?Hans KrankenbergJACC: Cardiovascular Interventions
- Access DeniedDrug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions24-Month Results of AcoArt IYongle Xu, Wei Guo, et al.JACC: Cardiovascular Interventions
- Access DeniedSimple Treatment for Complex Femoropopliteal Disease?Midterm Drug-Coated Balloon Results From the AcoArt I TrialBeau M. Hawkins, Benoy Varghese, et al.JACC: Cardiovascular Interventions
- Access DeniedSustainable Antirestenosis Effect With a Low-Dose Drug-Coated BalloonThe ILLUMENATE European Randomized Clinical Trial 2-Year ResultsMarianne Brodmann, Henrik Schroeder, et al.JACC: Cardiovascular Interventions
- Access DeniedComparison of 2 Different Drug-Coated Balloons in In-Stent RestenosisThe RESTORE ISR China Randomized TrialYundai Chen, Lili Wu, et al.JACC: Cardiovascular Interventions
- Access DeniedDrug-Coated Balloons for In-Stent RestenosisA Fierce Fight for a “Me-Too” SpaceJuan F. GranadaJACC: Cardiovascular Interventions
Pages
Advertisement